The identification of cytoplasmic loss of CDK1 in lung cancer as an independent poor prognostic factor in NSCLC patients is a surprising finding with potential clinical significance in that CDK1 may play an important role in chemotherapeutic responsiveness distinct from its role in cell cycle progression. Here, CDK1 is linked to non-small cell lung carcinoma.